Articles

Results 1 to 4 of 4


Juxtaposing Helsinn with Pharmaceutical Trademarks

USA - July 31 2020 Pharmaceutical branded drug developers interested in obtaining trademark protection should take note of the Supreme Court holding in Helsinn v. Teva…

Karen Kline

Playing Your Cards Right: Arguments Against Obviousness Can Be Detrimental for Satisfying the Written Description Requirement

USA - July 2 2020 It is important at the initial stages of drafting an application to distill down the points of novelty, determine why the claimed invention is…

Brandon A. Chan, Thomas J. Kowalski, Deborah L. Lu.

FDA Publishes Redraft of 510(k) Third Party Review Program

USA - November 20 2018 Section 523 of the Federal Food, Drug, and Cosmetic (FD&C) Act codifies the 510(k) Third Party Review Program (3P Review Program), which authorizes…

Carolyn A. Alenci, Frederick R. Ball, Lisa W. Clark, Stephen M. Honig, Jennifer A. Kearns, Vicki G. Norton, Jiazhong (Jason) Luo, Ph.D., JOHANN YI-DER LIN, PH.D.

American Chemical Society Entrepreneurial Showcase 2015

USA - May 18 2015 The American Chemical Society held its annual Entrepreneurial Showcase in San Diego at Jannsen Labs (J&J Research Labs) in April 2015. ACS holds the…